Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Beta-3 adrenergic receptor | ||
Ligand | BDBM50160821 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_310482 (CHEMBL834517) | ||
EC50 | 36±n/a nM | ||
Citation | Sawa, M; Mizuno, K; Harada, H; Tateishi, H; Arai, Y; Suzuki, S; Oue, M; Tsujiuchi, H; Furutani, Y; Kato, S Tryptamine-based human beta3-adrenergic receptor agonists. Part 3: improved oral bioavailability via modification of the sulfonamide moiety. Bioorg Med Chem Lett15:1061-4 (2005) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Beta-3 adrenergic receptor | |||
Name: | Beta-3 adrenergic receptor | ||
Synonyms: | ADRB3 | ADRB3R | ADRB3_HUMAN | B3AR | Beta-2 adrenergic receptor and beta-3 adrenergic receptor | Beta-3 adrenoceptor | Beta-3 adrenoreceptor | adrenergic Beta3 | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 43534.88 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 408 | ||
Sequence: |
| ||
BDBM50160821 | |||
n/a | |||
Name | BDBM50160821 | ||
Synonyms: | CHEMBL182770 | Methanesulfonic acid 3-((R)-2-{(R)-2-hydroxy-2-[3-(3-methyl-but-2-enylamino)-phenyl]-ethylamino}-propyl)-1H-indol-7-yl ester | ||
Type | Small organic molecule | ||
Emp. Form. | C25H33N3O4S | ||
Mol. Mass. | 471.612 | ||
SMILES | C[C@H](Cc1c[nH]c2c(OS(C)(=O)=O)cccc12)NC[C@H](O)c1cccc(NCC=C(C)C)c1 |wU:19.21,1.0,(1.08,-.52,;1.1,1.02,;2.42,1.8,;3.76,1.02,;3.76,-.52,;5.08,-1.3,;6.43,-.52,;7.75,-1.28,;7.72,-2.83,;9.06,-3.6,;10.38,-2.83,;9.06,-5.15,;7.72,-4.37,;9.08,-.52,;9.08,1.02,;7.75,1.77,;6.43,1.02,;-.24,1.8,;-1.56,1.02,;-2.9,1.77,;-2.92,3.32,;-4.24,1,;-4.24,-.55,;-5.58,-1.32,;-6.92,-.55,;-6.92,1,;-8.24,1.77,;-9.58,1,;-10.9,1.76,;-12.23,.98,;-13.57,1.75,;-12.23,-.56,;-5.58,1.77,)| | ||
Structure |